Gwynn Williams - Net Worth and Insider Trading
Gwynn Williams Net Worth
The estimated net worth of Gwynn Williams is at least $57 Million dollars as of 2024-11-08. Gwynn Williams is the Director of Biomarin Pharmaceutical Inc and owns about 812,565 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $54 Million. Gwynn Williams is also the 10% Owner of Kidoz Inc and owns about 26,987,999 shares of Kidoz Inc (KDOZF) stock worth over $3 Million. Details can be seen in Gwynn Williams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gwynn Williams has not made any transactions after 2017-06-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gwynn Williams
Gwynn Williams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gwynn Williams owns 3 companies in total, including Armata Pharmaceuticals Inc (ARMP) , Biomarin Pharmaceutical Inc (BMRN) , and Kidoz Inc (KDOZF) .
Click here to see the complete history of Gwynn Williams’s form 4 insider trades.
Insider Ownership Summary of Gwynn Williams
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARMP | Armata Pharmaceuticals Inc | 2014-02-18 | 10 percent owner |
| BMRN | Biomarin Pharmaceutical Inc | 2003-07-28 | director |
| KDOZF | Kidoz Inc | 2017-06-16 | 10 percent owner |
Gwynn Williams Latest Holdings Summary
Gwynn Williams currently owns a total of 2 stocks. Among these stocks, Gwynn Williams owns 812,565 shares of Biomarin Pharmaceutical Inc (BMRN) as of July 28, 2003, with a value of $54 Million and a weighting of 94.82%. Gwynn Williams also owns 26,987,999 shares of Kidoz Inc (KDOZF) as of June 16, 2017, with a value of $3 Million and a weighting of 5.18%.
Latest Holdings of Gwynn Williams
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2003-07-28 | 812,565 | 66.94 | 54,393,101 |
| KDOZF | Kidoz Inc | 2017-06-16 | 26,987,999 | 0.11 | 2,968,680 |
Holding Weightings of Gwynn Williams
Gwynn Williams Form 4 Trading Tracker
According to the SEC Form 4 filings, Gwynn Williams has made a total of 0 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 68,700 shares on July 28, 2003, which brought Gwynn Williams around $687,000.
According to the SEC Form 4 filings, Gwynn Williams has made a total of 0 transactions in Kidoz Inc (KDOZF) over the past 5 years. The most-recent trade in Kidoz Inc is the acquisition of 900,000 shares on June 16, 2017, which cost Gwynn Williams around $306,000.
Insider Trading History of Gwynn Williams
- 1
Gwynn Williams Trading Performance
GuruFocus tracks the stock performance after each of Gwynn Williams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gwynn Williams is -6.38%. GuruFocus also compares Gwynn Williams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gwynn Williams within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gwynn Williams's insider trading performs compared to the benchmark.
Performance of Gwynn Williams
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.26 | | | | | |
| Relative Return to S&P 500(%) | 3.28 | | | | | |
Gwynn Williams Ownership Network
Ownership Network List of Gwynn Williams
Ownership Network Relation of Gwynn Williams
Gwynn Williams Owned Company Details
What does Armata Pharmaceuticals Inc do?
Who are the key executives at Armata Pharmaceuticals Inc?
Gwynn Williams is the 10 percent owner of Armata Pharmaceuticals Inc. Other key executives at Armata Pharmaceuticals Inc include Corporate Controller and PFO Richard Rychlik , director & Chief Executive Officer Deborah Birx , and Chief Financial Officer Julianne Averill .
Armata Pharmaceuticals Inc (ARMP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Armata Pharmaceuticals Inc (ARMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Armata Pharmaceuticals Inc (ARMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Armata Pharmaceuticals Inc (ARMP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Armata Pharmaceuticals Inc Insider Transactions
Gwynn Williams Mailing Address
Above is the net worth, insider trading, and ownership report for Gwynn Williams. You might contact Gwynn Williams via mailing address: Ballacarrick, Pooilvaaish Road, Castletown Y8 Im9 4pj.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
